As of 2025-07-16, the Fair Value of Procept Biorobotics Corp (PRCT) is -8.15 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 58.01 USD, the upside of Procept Biorobotics Corp is -114.05%.
With the market price of 58.01 USD and our fair value calculation, Procept Biorobotics Corp (PRCT) is not a good investment. Investing in PRCT stocks now will result in a potential loss of 114.05%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 5Y Avg | |
| Net income | -53.02 | -59.85 | -87.15 | -105.90 | -91.41 | -79.47 |
| YoY growth | -26.30% | -12.88% | -45.61% | -21.51% | 13.68% | -18.53% |
| Market Cap (mil) | 3,209.69 |
| P/E | |
| Forward P/E |
| EPS | -1.63 |
| Avg earnings growth rate | -18.53% |
| TTM earnings | -90.19 |